Plasmodium falciparum populations, transmission dynamics and infection origins across Papua New Guinea

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Sample collections, DNA extractions and molecular diagnosis were funded by the Global Fund to end AIDS Tuberculosis and Malaria (GFATM). Genetic and genomic data collection for this was funded through a National Health and Medical Research Council (NHMRC) of Australia Project Grant Number GNT1027108. IM and MB are supported by NHMRC Research Fellowships (GNT1155075, GNT1102971). The authors acknowledge the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institute Infrastructure Support Scheme (IRIISS).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics and Informed Consent. All samples were collected as part of ongoing studies in PNG investigating the impact of intensified malaria control efforts since 2004. All samples were collected with written informed consent from individuals or if children, consent was obtained from their parents, and guardians. Ethical approval for the study was obtained from the Papua New Guinea Institute of Medical Research Institutional Review Board (IRB 11/21, 12/29), the PNG Medical Research Advisory Council (MRAC 12/03, 13/08), the Walter and Eliza Hall Institute Human Research Ethics Committee (HREC 12/06, 13/14) and Deakin Human Research Ethics Committee (2020-282, 2020-283).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes